OBJECTIVES:: There is concern that ischemia-modified albumin (IMA) levels measured by
albumin cobalt binding (ACB) assay reflect mainly albumin concentrations rather than …

Systemic sclerosis (SSc) is a connective tissue disease characterized by widespread
vascular lesions and fibrosis of the skin and internal organs. In SSc, vasospasm causes …

Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

After reading this article, the reader should understand the current state of the albumin
cobalt binding test's ability to measure ischemia modified albumin and understand what …

Background: Clinical diagnoses were correlated with results of a Co (II)–albumin binding
assay in 167 patients treated at an emergency department of a health maintenance …

Recently a new biological marker, Ischemia Modified Albumin (IMA®), measured by the
Albumin Cobalt Binding (ACB®) test, was introduced for detection of myocardial ischemia …

Ischemia-modified albumin (IMA) has been proposed as a biological marker of myocardial
ischemia (1, 2). Exposure to ischemic myocardium modifies circulating albumin at its NH2 …

Background: In the presence of ischaemia, albumin undergoes changes resulting in the
formation of ischaemia-modified albumin (IMA). Increased serum concentrations of IMA have …

The diagnostic approach to acute myocardial infarction (AMI) is still one of the most
challenging and controversial medical issues. Although the measurement of cardiospecific …